Hist ®t Controlled Substances ArkansasPursuant to the provisions of Arkansas Code Annotated § 5-64-201 and § 5-64-216 of the laws of the State of Arkansas, the Director of the Arkansas Department of Health or duly authorized agent, as specified by law, is giving public notice of the publication of the List of Controlled Substances for the State of Arkansas. Due consideration has been yiven applicable federal cegulations, current scientific knowledge regarding the listed substances, the evidence of actual or relative potential for abuse, the history and current patterns of abuse, the risk to the public health, and potential to produce psychic or psychological dependence liability. Based on these considerations the attached listing of the Schedule of Controlled Substances and the corresponding drugs that are included in each schedule is hereby promulgated hy the Director of the Arkansas Department of Health as the List of Controlled Substances for the State of Arkansas. Fach controlled substance or basic class thereof has been assigned an “Administration Contrelled Substance Code Number” for purposes of identification. ‘hese numbers are for internal management and are used as a means to identify substances with complex and cumbersome chemical names Next to the code number is the date the substance was placed in schedule by the Director of the Arkansas Department of Health. I, Shane David, Pharm.D., Section Chief of Pharmacy Services for the Arkansas Department of Health, do hereby certify that the documents attached hereto are true and correct copies of the current List of Controlled Substances adopted by the Arkansas State Board of Health in accordance with Arkansas state law. Sawa Cesiel Shane David, Pharm.D., Section Ch: Pharmacy Services Branch STATE OF ARKANSAS ) ) couNTY OF SALINE ) I, Marci Middleton, do hereby certify that Shane David, Pharm.0., well known to me, appeared before me and signed the above ssserent document. Sworn and subscribed to before me this. ae day of ecmsgere -45- ae My connission expires YATES ips 25,205 anARKANSAS DEPARTMENT OF HEALTH LIST OF CONTROLLED SUBSTANCES SECTION I AUTHORITY The following scheduling of these controlled substances has been h promulgated pursuant to Arkansas Stat. Ann. §5-64-201 and $5-64-216. SECTION II PURPOSE Due consideration has been given applicable Federal regulations, current scientific knowledge regarding the listed substances, the evidence of actual or relative potential for abuse, the history and current patterns of abuse, the risk to the public health, and potential to produce psychic or psychological dependence liability SECTION III GENERAL REQUIREMENTS (Attached copy of the listing of scheduling of controlled substances) SECTION IV REPEAL All lists of repealed edules of controlled substances in conflict herewith are hereby CERTIFICATION ‘This will certify the following list of scheduling of controlled substances wa adopted by the Arkansas State Board of Health at a session of the Board held in Little Rock, Arkansas on the 1% day of August, 2019, and after a Public Hearing on the 26% day of September, 2019, held in Little Rock, Arkansas at the State Department of Health Building. Wathaniel-Saith, WD, MPH Director, Arkansas Department of HealthARTICLE IT Schedule T Page t Tal Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand nane listed in this section. fach drug or substance has been assigned Controlled Substances Code Number set forth opposite it. (b) Qpiates designated, the DER in nother schedule, any of the following opiates, including their isomers, esters, ethers, salts, and ealts of isomers, esters, and ethers, whenever the Warcotic Drugs) Unless specifically excepted or unless listed existence of such isomers, esters, ethers, salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers) : (1) Acetyl-alpha-mothyl fentanyl (N-(1-[1-methy1-2- phenethyl)-4-piperidinyl]-N-phenylacetamide] ~ (2) Acetylmethadol (3) Allylpredine =. (4) Alphacetylmethadol (except Levo-alphacetylmethadol (AM) (5) Alphameprodine (6) Alphamethadol 9815- (2-86) 9601* 9602" 9603+ 9604+ 9605+ (7) Alpha-methyl fentanyl [N-[1~(alpha-methyl-beta-phenyl} etayl-d-piperidy!)propronani lide; 1 (1-methy1~ 2-phenylethy1) -4 (N-propani lido) piperidine) (8) Alpha-methyl thiofentanyl (N-[1-methy1-2-(2thienyl) ethyl-4-piperidiny1]-N-phenylpropanamide) ~ (9) Benzethidine -: (10) Betacetyimethadol (11) Beta-hydroxyfentanyl (N-[1~(2-hydroxy-2-phenethyl) ~4-piperidinyl(]-N-phenylpropanamide} (12) Beta-hydroxy-3-nethyl fentanyl 9B14- (6-82) 9832- (2-86) 9606+ 9607" 9830-(2-86) [other name: N-[1-(2-hydzoxy-2-phenethyl) ~3-methyl~ 4-piperidinyl]-N-phenylpropamamide) ~- ~ (13) Betamepzodine (14) Betamethadol = (15) Betaprodine (16) Clonitazene (17) Dextromoramide (18) Diampromide (19) Diethyithiambutene -. (20) Difenoxin =. (21) Dimenoxado1 (22) Dimepheptanol (23) Dimethyl thiambutene - (24) Dioxaphetyl butyrate - (25) Dipipanone ~ ~ (26) Behylmethylthiambutene (27) Btonitazene (28) Btoxeridine (28) Furethidine (30) fydroxypethidine -- (31) Ketobemidone -- (32) Levomoramide =. (33) _Levophenacyimorphan (34) 3-Methyl fentanyl (N={3-Methyl-1- (2-phenylethy1) =4= piperidyl] -N-Phenypropanamide} 9831- (2-86) gea8* 9609 geli* 9612+ 9613+ 9615* 9616 o168* 9617 9618+ 3619 9621+ 3622¢ 9623 9624¢ 3625+ 9626+ 9627" 3628+ 9629 ea1+ 9813-10-85 H(35) 36) @7) (ey (3s) (40) (a1) (42) (43) (4a (45) (45) “a7 (43) (49) (50) (1) (52) (53) (54) (55) 156) (sr) (58) (39) (0) (en) (62) (63) (oa (69) (66) wr) (68) 69) (0) Page 2 3-methylthiofentanyl (N-[ (3-methy1-1-(2thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide) 9933-(2-86) Morpheridine 9632" MePP (1-methyl-4-pheny|-4-propionoxypiperidine)--- 9661-(10-85) Noracymethadol 9633° Norlevorphanel = 9634" Normethadone 9635+ Norpipanone - 9636¢ Para-fluorofentanyl (N=(4-flucrophenyl) -N-[1=(2~ phenenthyl) ~4~piperindinyl }propananmide ~. 9812-(11-86) PEPAP 1-(2-phenylethyl)~4-phenyl-4 acetyloxypiper- idine =- 9663- (10-85) Phenadoxone ~. 3637" Phenampromide = 9638+ Phenonorphan sea7* Phenoperidine = 9641" Piritramide ~ 9642+ Proheptazine 9643" Properidine =. oeaar Propicam 3649* Racemoramide 9645+ niofentanyl (N=phenyl-N-[1~(2~thienyl} ethyl=4~ piperidinyl]-propanamide - Tilidine 9835- (2-86) 9750-(9-81} Teimeperidine = 9646" Acetyl fentanyl N-(1-phenethylpiperidin-4-yl) -N-phenylacetamide- 9821 Butyryl fentanyl N-(1-phenethylpiperidin-4-yl} -N-phenylbutyrami de Beta-hydroxythiofentanyl N-(1-[2-hydroxy-2- (thiophen-2=y1} ethyl] piperidin=4~y1}-N- phenylpropionamide: Acetyl fentanyl 4-methylphenethyl analog N- {1-[2=(4-methyipheny1) ethyl] ~4-piperidiny1}-N- phenyl-acetamide monohydrochloride Valeryl fentanyl N-phenyl-N[1-(2=phenylethyl) -4-piperidinyl |-pentanamide monohydrochloride Furanyl fentanyl N-(1~(2-phenylethy1) - 4-piperidiny!) -N-phenyl furan-Z-carboxamide~ Isobutyryl fentanyl 2~methyl-N-pheny1-N- (= (2-phenylethy1} ~4-piperidinyl] -propananide monohydrochloride Ocfentanil N= (2-fluorophenyl) -2-methoxy-N=[1= (2= phenylethyl) piperidin-4~ylJacetamide-- A-nethoxy butyryl fentanyl N-(4-methoxyphenyl) -N = (1-phenethylpiperidin=4-y1} butyramide monchydro chloride Para-fluorobutyryl fentanyl N- (4-fluorophenyl) -N- [1- (2-phenylethyl) ~4-piperidinyl}-butanamide mono hydrochloride Acetyl norfentanyl N-phenyl-N-4-piperidinyl-acetamide monohydrochloride All-7921 3, 4=dichloro=N- [ (1dimethylamino) cyclohexyl methyl |benzamide W-18 1-(4-nitropnenylethyl) piperidylidene-2-(4~ chloropheny)} sulfonamide W-15 1-phenylethylpiperidylidene-2-(4-chlorophenyl} sulfonamide MI-45 1-cyclohexy1-4~(1,2-diphenylethyl) piperazineoy (72) (73) wa Page 3 0-47700 trans~3, 4-dichloro-N-(2~(dimethylamino} cyclohexyl) N-methyl benzamide Acryl fentanyl N=|1-phenethylpiperidin=4-y1) -N= phenylacrylamide~ - 9832 A-Pluoroisobutyryl fentanyl N-(4=fluorophenyl} -N= (1-phenethylpiperidin~4-yl} isobutyramide- - 9824 Tetranydrofuranyl fentanyl N-(1-phenethylpiperidin~ 4-yl) “N-phenyltetrahydrofuran-2-carboxamide: ~ 9843, (c) Qpium derivatives: (Narcotic Drugs) Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and designation: an (2) By @ 15) (6) a (a) cn) (20) any a2) a3) aay as) as) an as) as) (20) (ay (22) (23) (24) (25) salts of isomers is possible within the specific chemical Acetorphine ~ 9319 Acetyldihydrocodeine - 9051+ Benzylmorphine = 9052+ Codeine methylbromide — = 9070* Codeine-N-oxide -. = 9053+ Cypranorphine - 9054+ Desomorphine -- = 90554 Dihydromorphine ~ — 9145+ Drotebanol 9335* Etorphine (except hydrochloride salt) 3056" Heroin — = 9200+ Eydromorphinol = 9301 Methyldesorphine = 9302+ Methyldinydromorphine ~ - 9304+ Morphine methylbromide = 9305* Morphine methylsulfonate ~ = 9306+ Morphine-N-oxide = 9307* Myrophine =: = 9308+ Nicocodeine = 9309* Micomorphine =. = 9312+ Normozphine = 9313" Pholcodine ‘Thebacon Mitragynine J-Hydcoxymitragynine 9314+ 9315" (a) Hallueinogenic substances: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any contains any of such salts, chemical desis includes the a (a al quantity of the following hallucinogenic substance, or which of its salts, isomers, and salts of isomers whenever the existence , isomers, and salts of isomers is possible within the specific gnation (for purposes of this paragraph only, the term isomer’ optical, position and geometric isomers) alpha-cthyltryptamine ~ 7249-(12-93) Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; alpha~BY; and ABT. 4-brono-2, 5~dimethoxy-amphetamine - 7391 Some trade or other names: 4-bromo-2,5-dimethoxy- alpha-methylphenethylamine; 4-bromo-2,5~DMA 4-bromo-2, 5-dimethoxyphenethylamine ~ 7392=(8-95) Sone trade or other names: 2-(4-bromo-2, 5~dimethoxyphanyl)-L 2C-B, Nexus. aminocthane; alpha-desmethy1 DOB; 2, S-dimethoxyamphetamine ~ 7396"a ) mo 1) @ op an 2) a3) aay (15) (16) an cg) 1g) (20) (2a) (225 (23) (24) (25) (26) Page 4 Some trade or other names: 2,5-dimethoxy-alpha~ methylphenethylamine; 2, 5-DMA. 2, S~dimetoxy=4~ethylamphetamine ~ 7399- (3-88) Some trade or other names: DOET. 2, 5~dimethoxy=4~ (n} ~propylthiophenethylamine~ 7348-(1-05) Some trade or other names: 2C-T-!. 4-methoxyamphetamine moana vais Some trade or other names: 4-methoxy-alpha- methylphenethylamine; paramethoxyamphetamine; PMA. S-methoxy~3, d-nethylenedi oxy-amphetamine m= 7401 4-methy1~2, 5-dimethoxyamphetamine 7395+ Some trade’and other names: ¢-methyl-2,5-dimethoxy- alphanethylphenethylamine; "DOM"; and "STP" 3,4-methylenedioxy amphetamine --- 7400+ 3; A-methylenedioxymethamphetanine 7405-10-85) Some trade or other names: MDMA) 3, 4-methylenedioxy-N-ethylamphetamine 7404- (6-90) Some trade or other names: N- ethy-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA; MDEZ MOEA. N-hydroxy-3, 4-methylenedioxyamphetamine — 7402- (6-90) Sone trade or other names: N-hydroxy-alpha-nethyl~3, 4(methylenedioxy) phenethylamine; N-hydroxy MDA 3,4, 5~trimethoxy amphetamine ~- 71390* S-methoxy-n,-dimethyltryptamine 5-MeO-DMT- 74315 (01-11) alpha-methyltryptamine ~- 7432-(7-05) Some trade or other names: ANT Bufotenine ~. 433+ Some trade and other names: 3-(beta~ Dimethylaminoethyl)-S-hydroxyindole; 3- (2 dimethylaminoethyl)~5~indolol; N,N-dimethyl serotonin: Schydroxy-N,N-dimethyltryptamine; mappine. 434+ Diethyltryptamine -- Sone trade or other name: Der. Dimethyltryptamine Some trade or other names: OMT. S-methoxy-N, N-diisopropyltryptanine — Some trade or other names: 5-MeO-DIPr. Thogaine Some trade and other names: T-Rthyl-6,6 betas 7,8,9, 10, 12, 13~octahydro-2-methoxy=6, 9methano-5i=pyr ido (2',2": 1,2) azepino [5,4-b] indole; Tabernanthe iboga. N,N-Diethyltryptamine; lysergic acid diethylamide 7315 Mescaline 7381* Parahexy] --------———neeeeene— 1374-(7-83) Some tvade or other names: 3-Hexyl-1-hydzoxy- 1, 8,9, 10-tetrahydro-6, 6, 3-trimethy1-6H-dibenzo [b, pyran; Synhexyl- Peyote === vase Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts. (Interprets 21 USC 812 (c), Schedule I {c) (12)) Neethyl-3-piperidyl benzilate = 7482"(2 (28) (23) Go) en (32) (33) aay (35) Ge, a) (Ga) Ga) (40) an (4a) (431 (al (45) (4) Page S N-methy1-3-piperidyl benzilate - 1484+ Psiloeybin <=. = 437° Pailocyn = - 7438* Ethylamine Analog of phencyclidine ~ 1455" Some trade or other names: Neethyl-1-phenylcyclohexylamine, (phenylcyelohexyl]ethylamine; N-(1-phenylcyclohexy2) ethylamine; cyclohexamines PCE. Pyrrolidine Analog of phencyclidine ~. 145e* Some trade or other names: 1-(1-phenylcyclohexyl}= pyrrolidine; PCPy; PAP Thiophene Analog of phencyclidine Some trade or other names: 1-[1-(2-thienyl) cyclohexyl] Piperidine; 2-Thienyl analog of phencyclidine; TecP; TCP. 1+[1-(2-Thienyl) cylcohexyl pyrrolidine Some other trade or ether names: TCPy. N,N-Dially1-5-Methoxytryptamine; Some trade or other names: 5'Meo DALT; 5S-Methoxy-DALT. 2>(4-chLoro~2, 5~dimethoxyphenyl) -N- | (2-methoxypheny}} methyl|ethanawine; 25C-NBOMe 2=(4=iodo-2, 5-dimethoxypheny1} -N- (2-methoxypheny1) methyl|ethanamine; 251-NBOMe 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine; 2C-E~ 2+(2,5-Dimethoxy-4-methylphenyl) ethanamine; 2C-D- 2-(4-Chloro-2, 5dimethoxyphenyl)ethanamines 2C-C: 2>(4-Tedo~2, 5~dimethoxyphenyl)ethanamine; 2C~ 2-[4- (Ethyl thio} -2, 5=dimethoxypheny! | ethanamin 2c: 2-[4- [rsopropylthic) ~2, 5~dimethoxyphenyl] ethanamine; 470 7473- (9-89) 20-14. = 3532 2-(2,5-Dimethoxyphenyl) ethanamine; 2C-H 7517 2-(2,5-Dimethoxy-4-nitro~phenyl) ethanamines 2C-N---~ 7521 (2, 5-Dimethoxy-4-(n) ~propylpheny!) ethanamine; 2c-P- 7524 2> (4-bromo~2, S-dimethoxyphenyl) -N- (2-methoxybenzyl} ethanamine; 25R-NBOMe 2-[[[2>(4-bromo~2, S-dimethoxyphenyl) ethyl ]amino] methyl) phenols 258-NeoH 2-{ [ [2 (4~Lodo-2, S~dimethoxypheny!) ethyl] amino]methyl] -pheno! 251-NBOR 2-(4-ethyl-2, S-dimethoxyphenyl) -N-[ (2-methoxyphenyl) methyllethanamine; ?5E-N8OMe 2=(2, 5~dimethoxyphenyl) -N= | (2methoxypheny1) methyl ]ethanamine; 25%-NBOMe 2=[[[2~(4-chloro=2, S=dimethoxypheny1} ethyl ]amino}methy1 | ~ phenol; 25¢-NROH 2-[112-(2, 5-dimethoxyphenyl) ethyl Jamino|methy!|-phenol; 25H-NBOA Unless specifically excepted or unless Listed in another schedule, any material, compound, mixture, or preparation which contains any quantity’ of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: aM @ Phenazepan ganma-hydroxybutyric acid (some other names includePage 6 GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxydutanoic acid; sodium oxybater sodium oxybutyrate}, and its known precursors and analogs == 2010-(2-01) Mecloqualone’ 2572¢ Methaqualone 25654 BLizolam (a)Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: wD (2) @ “ (9) 6) m (8) oy fo) ay >) cathinone ==. 1235- (3-88) [¢) CIS-4-Methylaminorex [ (+) CIS~4, 9-dihydro=4= methy1-S-phenyl-2-oxazolamine] Fenethylline N-Benzylpiperazine Some trade or other names: BZP, 1-Renzylpiperazine Neethylamphetamine N-[1-(1-benzy1~4-piperidy!] -N-phenylpropanamide. (benzylfentanyl}, its optical isomers, salts and salts of isomers’ = N-(1-(2-thienyl) methy1~4-piper idy!} -N-phenylpropan- mide (thenylfentanyl), its optical isomers, salts and salts of isomers penwnnnnn= 9834~ (2-86) N, N, Dimethylamphetamine (some other names: N, N Alpha-trimethylbenzeneethanamine; N, N, Alpha~ trimethylphenethylamine}, its salts, optical isomers, and salts of optical isomers =----—-—~ Methcathinone {some other names: 2-Methylamine-Proprophenone, alpha {methylamino) ~ Proprophenone, 2 (methylamino] -1-phenylpropan-1-one, alpha-N-Methylaminopropiophenone, monomethylpropion, ephedrone, N-methyleathinone, methycathinone, AL~464, AL=422, AL-463 and UR-1431), its salts, optical 1590- (6-90) 1503-(9-81) 7493- (1-05) 1475-(6-82) 9818- (2-86) 1480- (2-89) isomers and salts of optical isomers -. 1237-(12-93) Aminorex (some other names: aminoraphen, 2-amino-5 phenyl-2-oxazoline, or 4,5 dihyrdo-5-phenyl-2- oxazolamine, its salts, optical isomers, and salts of optical isomers ~ 1585-(12-93) Methyl-N-ethylcathinone (NEC) Any material, compound, mixture, or preparation, whether produced directly or indirectly from a substance of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis, that contains any quantity of the following substances, or that contains any of the following substances’ analogs, salts, isomers, and salts of isomers when the existence of the analogs, salts, isomers, and salts of isomers is possible within the specific chemical designation, with the following chemical structure is included in Schedule 1: a (2) 3) @) 1S) (6) o a) @) ao) an 4-Nethylmethcathinone (Mephedrone) 1248+ (3-11) Methylenedioxypyrovalerone (MDPV) =: (ny 3, 4-Methylenedioxy-N-methylcathinone (Methylone)-=--~ 7540~ (3-11) 4*Hethoxymethcathinone Gey 3+Fluoromethcathinone ~ Gay 4-Fluoromethcathinone or — Gey 1+ (1, 3-benzodioxol-S~y2) -2-methylamino) butan-i-one (Butylone) Alpha-Pyrrolidinopentiophenone (Alpha-PYP) 4-methyl-N-ethylcathinone (4-MEC) 4-methyl-alpha-pyrrolidinopropiophenone (4-MerPP) 2-(methylamino)~1-phenylpentan~1-one (Pentedrone)Page 7 (12) 1+[1, 3-benzodioxol-5-y1)-2- (methylamino) pentan~1-one (Pentylone,MBDP) (13) d-£luoro-Nemethylcathinone (4-FMC, Flephedrone} (14) 3-fluoro-Nemethyleathinone (3-FMC) (25) 1={naphthalen-2-yl)-2- (pyrrolidin~1-yl) pentan-1-one (Naphyrone) (16) Alpha-pyrrolidinobutiophenone ({Alpha]-PBP) or (27) A compound, unless listed in another schedule or a legend drug, that is structurally derived from 2-Amino-phenyl-1-propanone by modification or by substitution: (A) Tn the pkenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one (1) or more other univalent. substituents; (8) At the 3-position with an alkyl substituent; or (C) At the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure. (18) NoRthylpentylone, ox 1-(1,3-benzodioxol-5-y1)-2-(ethylamino} ~pentan~ iron Schedule II (a) Schedule 11 shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Bach drug or substance has been assigned the Controlled Substances Code Number set forth opposite it. (>) Narcotic Drugs: Substances, vegetable origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the Eollowing substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, cr by combination of extraction and chemical synthesis: (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone and naltrexone and their respective salts, but including the following: (1) Raw opium =. (2) Opium extracts = (3) Opium fluid extracts =. (4) Powdered opium ~ (5) Granulated opium =: 9600* 9610" 9620* 9639" 640% (6) Tincture of opium ~. 9630" (| Codeine = 3050" {8} Dihydroetorphine 9334+ (9) Ethylmorphine =: 9190" (10) Etorphine hydrochloride =. 3053+ (21) Ry¢recodone 9193+ (22) Bydeomorphone ~- 9190* (3) Netopon = 9260+ (14) Morphine 9300* (18) Oripavine =: 9330* (9-07) (16) Oxycodone 9143 (27) Oxymorphone 9652" (8) Thebaine 9333" (3) Tapentadol ~ 97a0- (5-09) (2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.*re) @) “) Page 8 opium poppy and poppy straw.* Coca leaves (3040) and any salt, compound, derivative, or preparation of coca leaves, (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers and derivatives}, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine er eegonine.* Concentrate or poppy straw (the crude extract of poppy straw in either liquid, solid or poder form which contains the phenanthrine alkaloids of the opium poppy), 9670.* [cl Qpiates: (Wareotie Drugs) Unless specifically excepted or unless in another Sct nedule, any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters and etiiers whenever the existence of such isomers, esters, ethers, and salts ia possible within the specific chemical designations: (Q) Alfentani1 9737 (2-87) (2) Alphaprodine =. go10* (3) Anileridine 3020+ (4) Bezitramide 3800* (5) Bulk Dextropropoxyphene (non-dosage forms) 9273-(9-81) (6) Carfentanil 9743- (9-88) (7) Dihydrocodeine 9120* (8) Diphenoxylate 9170+ (9) Fentany! =. 9B01* (10) Tsomethadone ~ 9226+ (11) Levo-alphacetylmethadol (LAAM) 9648~(12-93) (12) Levomethorphan 920% (13) Levorphanol. = 9220+ (14) Metazocine 92408 (15) Methadone ~ = 9250+ (16) Methadone-Intermediate, 4~cyano-2- dimethylamino-4, 4-diphenyl butane g2s4* (17) Moramide-Intermediate, 2-methyl-3- morpholino, 1-diphenylpropane- carboxylic acid -- 9802+ (18) Pethidine (Meperidine) - 9230° (19) Pethidine-Intermediate-A, 4-cyano-1- methyl~4-phenylpiperidine ~ 9232* (20) Pethidine-Intermediate-B, ethyl-4- phenylpiperidine=4-carboxylate ~ 9233 (21) Pethidine-Intermediate-C, 1-methyl-4- phenylpiperidine-4-carboxylic acid 9234+ (22) Phenazocine -. e715 (23) Piminodine 9730* (24) Racemethorphan 9732+ (25) Racemorphan = 9733+ (26) Remifentanil - 9739-(11-96) (27) Sufentanit 9740~(9-81) (a) Stimulants: Unless specifically excepted or unless listed in another schedule, quantity o! nervous sy: a (2) ‘any material, compound, mixture, or preparation which contains any f the following substances having a stimulant effect on the central stem: Amphetamine, its salts, optical isomers, and salts of its optical isomers = Methamphetamine, its salts, isomers, and salts 1100+Page 9 of its isomers - 1105+ (3) Lisdexamefetamine = 1205*(7-07) (4) Phenmetrazine and its salts - 1631+ 1724+ (5) Methylphenidate =, (e) Depressanta: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Amobarbital =: 21254 (2) Glutethimide 2880~(2-91) (3) Pentobarbital 2270* vane (4) Pheneyelicine (5) Secobarbital 2315* (£) Hallucinogenic Substances (Ty Nabilone = [Another name for nabilone: (+)) trans~3=(1,1- dimethylheptyl)~6, 6a, 7,8, 10, 10a-hexahydro”1— hydvoxy-6, €~dimethyl-9ii~dibenzo(b, d]pran=9-one] « (2) dronabinol in an oral solution in'a drug product approved for marketing by the U.S.Food and Drug Adminiatration? [(-)- delta-9-trans-tetrahydrocannabinol (delta-9-THC) |. = 7379- (11-87) 7365 (g) Immediate Precursor: Unless specifically excepted or unless listed in another Schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances: (1) Immediate precursor to Amphetamine and Methamphetamine: (2) Phenylacetone ~ ~ 8501-(3-80) Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl Ketone; methyl benzyl Ketone. (2) Immediate precursor to Phencyclidine (PCP) (4) l-phenylcyclohexylamine = (it) 1-piperidinocyclohexanecarbonitrile (BCC) (3) Immediate precursor to Fentanyl: (i) 4-anilino-N-phonethy]piperidine (ANPP) 8333+ (08-10) Schedule III (a) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Bach drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it (>) Stimulants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (2) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule 11 which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under Section 308.32,12) 13) (ay 15) Page 10 and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances: 1405* Benphetamine =~ 1228+ Chiozphentermine 1645+ Clortermine = 1es7+ Phendimetrazine 1615+ (c) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant. effect on the central nervous syste: a @ a mw @) () a (ay 3) ao) ay a2) a3) aa (a) Naezphine Any compound, mixture, or preparation containin’ (i) Anobarbital (11) Secobarbital (412) Pentobarbital (iy) enbutramide or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule. Any suppository dosage form containing (1) amobarbital (i) Secobarbital (it) Pentobarbital =. or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository. Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof: chlorhexadol Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act: Ketamine. its salts, isomers, and salts of isomers Some other names for Ketamine: (+=]-2- (2 Chloropheny!} ~2- (Methylamino) “Cyclohexanone. Lysergic acid -- Lysergic acid amide ~ Methyprylon fondiethylmethane 2600+ Sulfonethylmethane ~ 2605* Sulfonmethane ~-----~ 2610* Tiletamine and zolazepam or any salt thereof ~ 7295- (3-88) Some trade or other name for a tiletamine- zolazepam combination product: Telazol. Some trade or other names for tiletamine: 2 (ethylamino) -2~ (2-thienyl) ~cyclohexanone. Some trade or other names for zolazepa 4(2-fluorophenyl) ~6, 8-dihydro-1, 3,8, trimethylpyrazolo~ [3,4-e] [1,4,]“diazepin-7 (1-H}-one. flupyrazapon Perampanel ~ 2126+ 2aie* an 2020* (9-06) 2iz6* 2316+ zene 2190+ 2510+ 2012-(2-01) 1285~( 1-83) 7300* 7310+ 25754 2261-(11-13) 9400+Page I (e) Narcotic drugs: Unless specifically excepted or unless listed in another schedule? mM any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: [L) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium ~ (41) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts --===--. (11) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts ~. 9803" seo seo7* (iv) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnareotic ingredients in recognized therapeutic amounts ~ se08e (v) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams pez dosage unit, with one or moze active nonnarcotic ingredients in recognized therapeutic amounts ~ ~ 9809* (vi) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or moze active, nonnarcotic ingredients in recognized therapeutic amounts ~ gei0+ (2) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts, as set forth below: (i) Buprenorphine ~. ~ 9064~(6-85) (10-02 Transfer) (11) Reserved (£) Anabolic Steroids: Unless specifically excepted or unless listed in another Schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation: Ttems 1-28 ~ 4000-(9-91) (1) Boldenone; (2) Boldione; (01-10) (3) Chlorotestosterone (4-chlortestosterone) + (4) Clostebol; (5) Dehydrochlormethyltestosterone; (6) Desoxymethyltestosterone (01-10) (7) Dihydrotestosterone (4-dihydrotestosterone) ; (8) Drostanolones (9) Ethylestrenol; (10) Fluoxymesterones (11) Formebulone (formebolone} ;a Page 12 (12) Mesterolone; (13) Methandienone, Methandrostenclones (14) Methandranone; (18) Methandriol; (16) Methenolone; (17) Methy) testosterone; (18) Mibolerone; (19) Nandrolones (20) 19-Nor-4,9(10)-Androstadienedione (01-10) (21) Norethandrolone; (22) Oxandrolone; (23) Oxymesterone; (24) Oxymetholone; (25) Stanolone; (26) Stanozoiol; (2) ‘Testolactone; (28) Testosterone; (29) Trenbolone (30) Prostanoz0), (8-12) (1) Methasterone~: [e-12); and (32) Any salt, ester, or isomer of a drug or ‘substance described or list in this paragraph, if that salt, ester, or isomer promotes muscle growth. Exempt anabolic steroid products: Compounds, mixtures, or preparations that contain an anabolic steroid that have been exempted by the Director: NDC Number (1) Andro-Estro 90~; 0536-1605 (2) Androgyn L.A. 0456-1005 - Ivy Labs Inc. = Ivy Labs Inc. - Ivy Labs Inc. - Ivy Labs Inc. (3) Component 8-H in Process Pellets~ (4) Component 8-# in Process Granulation (5) Component T8=s in process Granulation~ (6) Component 78-5 in process Pellets (7) depanbxoGyn-- — 0456-1020 (8) Depo-Testadiol~ 0009-0253 (8) pepo-r.B. 2765-257 (10) deprEsTROGEN-: = 51698-257 (1) duomone ~ 52047-360 (22) puo-SPAN II-: - 0684-0102 a3) 43797-016 as) Pharmaceutics as) Pharmaceutics (16) Esterified Estrogens & Methyltestosterone, USP (0.625 mg/1.25mg) ~ Interpharn (11) Esterified Estrogens & Methyltestosterone, USP (1..25mg/2. Smg) ~ Intexpharm (18) Esterified Estrogens & Methyltestosterone (0.625mg/1.25nq) Tablet ANDAPharm (19) Esterified Estrogens % Methyltestosterone (1.25mg/2.5mg) Tablet: ANDAPharn (20) 0032-1026 2) (0032-1023 (22) 99243-570 (23) 9243-560 (24) Methyltestosterone & Esterified Estrogens (2.5ng/1.25¥g) ~ (25) Methyltestosterone & Esterified Estrogens (Half Lannett Cowy Page 13 Strength) (1.25mg/0. 625mg) ~ Lannett Co (26) PAN ESTRA TEs?- ~ 0525-0175 (27) Premarin with Methyltestosterone- - 0046-0879 (28) Premarin with Methyltestosterone— 0046-0878 (28) syntest 0.8. 6576-233, (30) Stntest 66576-230 (31) Synovex Hi in process bulk pellets: (32) Synovex Il in process granulation: (33) Synovex Plus in process granulation~ (34) Synovex Plus in process bulk pellets: Syntex Animal Syntex Animal Fort Dodge Fort Dodge (35) TRST-ESTRO Cypionates~ 0536-9470 (36) Testoderm with Adhesive 4mg/di - Alza Corp. (37) Testoderm 4ng/d- = 17314-4608 (38) Testoderm éng/a = 17314-4603 (39) Testodeem with Adhesive émg/a. = 17314-2836 (40) Testoderm in process fi1m~ - Alza Corp. (41) Testoderm with Adhesive in process film Alza Corp. (42) Testosterone Cypionate/Estradiol Cypionate injection! 94274-530 (43) Testosterone Cypionate/Estradiol Cypionate injection 0182-3069 (44) Testosterone Cyp 50 Estradiol Cyp 2~ 0814-7737 (45) Testosterone Cypionate/Estradiol Cypionate inject ion- 0364-6611 (46) Testosterone Cypionate/Estradiol Cypionate injection- 0402-0257 (47) Testosterone Enanthate/Estradiol Valerate injection: — 0182-3073 (48) Testosterone Enanthate/Estradiol Valerate injection nono 0364-6618 (49) Testosterone gnanthate/Estradiol Valerate inject ion- 0402-0360 (50) Testosterone Ophthalmic Solution~ ~ Allergan (51) Tilapia Sex Reversal Feed (investigational) Veterinary Anabolic Steroid Implant Products: Anabolic steroid products expressly intended for administration through implants in cattle or other nonhuman species exenpted by the Director. Ranger, Inc. Npc/DIN 021641-002 01969327 021641-004 0211641-006 0211641-005, 00093352 12799-807-10 12799-807-07 Boehringer Ingelheim Ivy Lab. (2) Component: £-1 (2) Component E-# (3) Component 12-8 (4) Component T-# =- (5) Component. 1-8 (6) F=70 Q) Finaplix-i (8) Finaplix-s (3) Reiter-old (10) BeLfer-o1d (11) Reifer-o1d (12) Tmplus-# ~ 0009-0434-01 (13) Implus-it 06-0434-01 01968327 (14) Masculinizing Feed for Fish (Invesitigational) ~ Rangen, Inc. 12799-811 12799-810 1298-808 0856-3901 syntex (15) Revalor-G (16) Revalor-H (7) Revalor-s (18) Synovex # (23) Synovex HPage 14 0956-3904 teigier Bros. (20) Synovex Plus = Tilapia Sex Reversal Feed {investigational} Tf veterinary products that are granted exempted status are subsequently distributed with the intent that they be used in humans, the distribution would be subject to the criminal sanctions of the CSA despite the drugs’ exempted status (g) Hallucinogenic substance: (1) Dronabinol (synthetic) in sesame oll and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved drug product [Some other names for dronabino! (6a R-trans)~6a,7,8, 10a-tetrahydro-6, 6, 9-trimethy1~3-pentyl~6l=dibenzo (b, a] phyran-1-ol, or (-)-delta 9~(trans)~ tetrahydrocannabinol) 7369-(11-87) Schedule IV (a) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Narcotic drugs: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: (QQ) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit siey* (2) Dextro propoxyphene (alpha~{+)~4-dimethylamino- 1, 2-dipheny1-3-methyl~2~propionoxybutane) ~- 9278- (11-87) (cl Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Alprazolam (2) Barbital 2882-(6-82) 145+ (3) Bromazepam 2748-(1-85) (4) Camazepam = 2749-(1-85) (5) Choral betaine ~ 2460+ (6) Choral hydrate = 2465+ (7) Chlordiazepoxide 2144+ (8) Clobazam 2781-(1-85) (8) Clonazepam 231 (20) Clorazepate = 2168+ (11) Clotiazepan ~ 2752~(1-85) (12) Cloxazolam 2753-(1-85) (13) Delorazepam = 2754-(1-85) (14) Diazepam -- = 27654 (15) Dichloralphenazone - 2467=(10-02) (16) Bstazolam ~- = 2796~(1-85) (17) BthchLorvynol 2540+ (18) Bthinamate 2545+ (19) Ethyl Loflazepate ~: 2758~(1-85)(20) (uy (22) (23) (24) (2s) (26) (27 (2a) (29) Go} au (2p (33) Gay (35) (36) a7) (38) (a) (40) ay (42) (43) (ay (43) (46) (a7) (4a) (49) (50) GL) (52) (3) a (55) 66) (@) Fenfiuramin Fludiazepam -: - Flunitrazepam - Plurazepam ~ Fospropofol. - Halazepam = Haloxazolam ~ - Ketazolam - Loprazolam - Lorazepam = Lormetazepam = Mebutanate - Medazepam - Meprobamate ~ - Methohexital, = Methylphenobarbital (mephorbarbital) - Midazolam = = Nimetazepam = ~ Nitrazepam - Nordiazepam ~: - oxazepam = = Oxazolam - - Paraldehyde — - petrichloral ~ Phenobarbital - Pinazepam = - Prazepam ~ = Quazepan =. — Temazepam ~ ~ Tetrazepam - Triazolam - Zalepion ~ - Zolpidem ~ - Zopiclone~ - Alfaxalone. - Carisoprodol - Tramadol ~ = Suvorexant Page 15 2759-(1-85) 2163-(1-85) 2167" 2138- (11-09) 2762-(6-82) 2771=(1-85) 2772~(1-85) 2773-(1-88) 2885+ 2774~ (1-85) 2a00+ 2636~(1-85) 2820* 2264" 2250+ 2884-(1-85) 2837-(1-85) 2834-(1-85) 2838~(1-85) 2835+ 2a39* 25854 2591+ 2285+ 2883- (1-85) 2164+ 2881-(11-86) 2925-(9-81) 2886- (1-85) 2887-(7-83) 2781 (9-99) 2783-(12-93) 2784~ (01-06) 2731-(02-14) 8192-(4-97) 9752-(8-07) 2223-(8-14) Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and’ salts of isomers is possible: a (ce) Stimulants: Fenfluramine ~- 1670" unless specifically excepted or unless listed in another schedule, any material, compound, mixtuce, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: ay 2) Bp «ay 15) 6) (6) am Cathine ((+)-Norpseudeophedrine) Diethylpropion - Fencamfanin = Fenproporex - Mazindol - Mefenorex Modafinil Pemoline (including organometallic complexes 1230- (3-88) 1610" 1760- (388) 1575~ (3-88) 1605- (6-82) 1580- (3-88) 3680- (1-39)Page 16 and chelates thereof) 1930* (9) Phentermine _—- ieao* (20) Pipradrol -. 1750- (9-81) {11) Sibutramine 1675- (2-98) (12) SPA ((-)~1-dimethylamino~1,2,diphenylethane) =---= 1635-(9-81) (13) Loreaserin --——. — 1625- (6-13) (£) Other substances: Unless specifically excepted or unless listed in another Schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts; isomers whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: (1) Pentazocine 9709~(4=79) (2) Butorphanol 9720~(4-97) (3) Nalbuphine (4-97) (4) Bluxadoline 9728 Schedule V (a) Schedule V shall consist of the drugs and other substances by whatever official name, common cr usual name, chemical name, or brand name designated, Listed in this section. (b) Narcotic Druga: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs and their salts, as set forth below. Reserved (c) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, oF preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall Include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon ‘the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone: + (1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams. * (2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams. * (3) Not more than 100 milligrams of ethylmorphine per 100 milliliters ox per 100 grams. * (4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit. * (5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grans. + (6) Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit (d) Stimulants: unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which containg any quantity of the following substances having stimulant effect on the central nervous system, including its salts, isomers and salts of isomers: (1) ‘Pyrovalerene ~ = 1485~(3-88) (2) Ephedrine: ~{-(ethylamino) ethy1}benzene-methanol ; (20-95) a-({-(methylamino) ethyl}benzyl alcohol; 2-methylamino~1-pheny1-1-propanol i-phenyl=1-hydroxy-2-methylaminopropanes 1-pheny1-2-methylaminopropanol; a ~ hydroxy-b-methylaminopropylbenzene?Page 17 a product which occurs in the Chinese herb Ma Huang (Ephedra vulgaris, mphedra sinica Stapf., Ephedra equisetina Bunge, Gnetaceae) in several other Ephedra spp. (3) Phenylpropanolamine ~ (4) Pseudoephedrine (7-08) (7-05) Pursuant to Ark. Code Ann. § 5-64-212 as amended in 2005, this Schedule V classification shall NOT apply to any ephedrine, phenylpropanclamine, or psoudoephedrine in liquid, liquid capsule, or liquid gel capsule form. However, sales Limits mandated by Statute shall apply to all products with ephedrine, phenylpropanolamine, or pseudoephedrine as 2 listed ingredient regardless of the dosage form, (e) Depressants: Unless specifically exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers (1) Pregabalin [(8)-3~(aminomethy1)~ S-methylhexanole acid) 2782-(01-061 (2) Lacosamide ~=--—~---=-----==. = 2146-05-03) (@) Brivaracetam ===. = 2710 (4) other substances (1) A drug product in finished dosage formulation that haa been approved by the U.S. Food and Drug Admin- istration that contains cannabidiol (2-[1R-3-methyl ~6R- (1-methyletheny1} -2~cyclohexen-1-y1]~-pentyl-1, S-benzenediol} derived from cannabis and no more than 0.1 percent (w/w) residual tetrahydrocannabinols. Schedule vi** Ta)_In addition to any substance placed in Schedule VI by the Director of the Department of Health under § 5-64-214, any material, compound, mixture, or preparation, whether produced directly or indirectly from a substance of vegetable origin cr independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, that contains any quantity of the following substances, or that contains any of their salts, isomers, and salts of isomers when the existence of the salts, isomors, and salts of isomers 1s possible within the specific chemical designation, is included in Schedule V1 (1) Marijuana (2) Tetvahydrocannabinols, unless the tetrahydrocannabinol is: (A) Contained in hemp-derived cannabidiol; (B) Not more than three-tenths of one percent (0.38)of the hemp derived cannabidiol on a dry weight basis as verified by a nationally accredited laboratory for quality, purity and accuracy standards; and (c) Not approved by the United States Food and Drug Administration for marketing as a medication: (2) A synthetic equivalent of: (A) The substance contained in the Cannabis plant; oF (B) The substance contained in the resinous extractives of the genus Cannabis; (4) Salvia divinorum or Salvinorin A, which includes all parts of the plant presently classified botanically as Salvia divinorum, whether growing or not, the seeds of the plant, any extract from any part ef the plant, and every compound, manufacture, derivative, mixture,Page 18 or preparation of the plant, its seeds, or its extracts, including salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation: (5) Synthetic substances, derivatives, or their isomers in the chemical structural classes described below in subdivisions (a) (5) (A)=(J) of this section and also specific unclassified substances in subdivision {a)(5)(K) of this section. Compounds of the structures described in this subdivision (a)(5), regardless of numerical designation of atomic positions, are included in this subdivision (a)(5). The synthetic substances, derivatives, or their isomers included in this subdivision (a| (5) are: (®) (i) Tetrahydrocannabinols, including without limitation the following: (a) Delta-1 cis or trans tetrahydrocannabinol, and its optical isomers; (b) belta-6 cis or trans tetrahydrocannabinol, and its optical isomers; and (c) Delta~3.4 cis or trans tetrahydrocannabinol, and its optical isomers. [4i) Dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the United States Food and Drug Administration is not a tetrahydrocannabinol under this subdivision (a) (5) (A); (5) Naphthoylindoles, or any compound structurally derived from 3- (1-naphthoy1) indole or 1H-indol~3-y1-(1-naphthyl}methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N= methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including without limitation the following (1) GWH-007, or 1-pentyl~2-methyl-3-(1-naphthoyl} indoles (4i) JWH-015, or 1-Propyl-2-methyl-3-(1-naphthoyl) indole? (S41) gwH-018, or 1-Propyl-3-(1-naphthoy!) indole; (iv) gWH-019, or 1-Hexy1-3-(1-naphthoyl) indole; (vy) SWH-073, or 1-Buty1~3-(1-naphthoyl) indole; (vi) dWH=081, or 1-Penty1~3~(4-methoxy=1-naphthoy1) indoles (vit) JWH-098, or I-pentyl-2-methyl~3-(4-methoxy-1~ naphthoy}) indole (viii) JWH-122, or 1-Pentyl~3~[4-methy1-1-naphthoy1) indole; (1x) JWH-164, of 1-penty1~3~(7-methoxy-1-naphthoy1) Indole; (x) Jall-200, or 1-[2~(4-morpholiny) ethyl] =3~(1-naphthoy!} indoles (x1) dwH-210, or 1-Penty1-3-(4-ethyl-1-naphthoy1) indole; (xii) JwH-398, or 1-Penty1-3-(4-chloro-1-naphthoyl) indoles (xiLi] AM-2201, or 1-(5-fluoropentyl) -3- (1-naphthoy1) indoles (xiv) MBM2201, ox (1=(5-fluoropentyl) -1i-indol=3~y1) (4=methy1~ I-naphthalenyl)-methanones and (xv) BAM2201, or (1=(5=f1uoropenty1) ~1M-indol-3-y1) (4-ethy1- i-naphthalenyl) -methanone; (xvi) THJ-2201, or [1-(5-fluoropenty1)-1s-indazol- 3-y1] (naphthalen-1-yl)methanone; Naphthylmethylindoles, or any compound structurally derived from an H=indol-3-y1-(1-naphthyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or (c)Page 19 not further substituted in the indole ring to any extent and Whether or not substituted in the naphthyl ring to any extent, including without limitation the followin: (2) Jai=175, of 1-Penty1-18-indol-3-yl-(1-naphthy1)methanes and (11) J=184, of 1-Penty1-18-3-y1~ (4-methy1-1- naphthyl )methane; (D) Naphthoylpyrreles, or any compound structurally derived from 3-(1-naphthoyl) pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkyimethyl, cycloalkylethyl, 17 (N-methy1-2- piperidinyl)methy1, or 2-(4-morpholinyl} ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether ox not substituted in the naphthyl ring to any extent, including without Limitation JWH-307, or (5-(2- Hluoropheny!) ~1-pentylpyrrol-3-y1) -naphthalen-1-ylmethanone; (B) Naphthylmethylindenes, or any compound structurally derived from 1-(1-napthylmethyl) indene with substitution at the 3- position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1~{N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including without limitation JwH-176, or E=3=[1-(1- Naphthalenylmethylene] -1#~inden-3-yl) pentane; (F) Phenylacetylindoles, or any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1~(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including without. limitation the following: (1) JWH=201, or 2~(4-methoxyphenyl) =1-(1-pentylindol-3- yLlethanone: (41) GwH-203, or 1-Penty1-3~(2-chlorophenylacetyl) indole; (iii) JWH-250, or 1-Pentyl-3- (Z-methoxyphenylacetyl) indole; (iv) SWH-252, or 1-Ponty1-3-(2-methylphenylacetyl) indole; and lv) RCS-8, or 1-(2-cyclohexylethy1}=3-(2~ mathoxyphenylacety1) indole; (G) Cyclohexylphenols, or any compound structurally derived from 2>(3chydroxycyclohexyl) phenol by substitution at the 5- position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkyimethyl, cycloalkylethy1, 1-(N-methy1-2- piperidinyl)methy1, or 2~(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent, including without limitation the following: (2) CP 47,497 5-(1, 1-dimethyihepty1) =2~[{1R, 38) -3- hydroxyeyelohexy)| ~phenol: (41) Cannabicyclohexanol or cP 47,497 C8 homologue, or 5=(1,1- dimethyloctyl) =2~ (18, 38) =3+hydroxycyclohexyl}=phenol; and (ii) CP 59,940, oF 9(1, 1-dimethytheptyl) ~2-( (1R, 28) -5~ hydroxy-2"(3-hydroxypropyl) cyclohexy? )~phenol (4) Benzoylindeles, or any compound structurally derived from a 3 (oenzoyl) indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, eycloalkyimethyl, cycloalkylethyl, 1-(N-methy1-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether orPage 20 not further substituted In the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including without limitation the following: a any Gil tiv) mm AM=694, or 1~(5~f1uoropentyl) ~3-(2=iodobenzoyl) indoles RCS-4,'or 1-Pentyl-3-(4-methoxybenzoyl) indoles WIN~48,098 or Pravadoline, or (4-Methoxyphenyl) ~(2- methyl~1-(2-(4-morphol iny1) ethyl} indol~3-y]methanones AM-2233, or 1-[(N-methylpiperidin-2-y1}methy) ]~3~(2~ iodobenzoyl] indoles and RCS-4 (C4 homologue) or (4-methoxyphenyl) (1-butyl-18~ indol~3-y1) ~methanone; (1) Adamantoylindoles, or Adamantoylindazoles, including Adamantyl Carboxamide Indolés and Adamantyl Carboxamide Indazoles, or any compound structurally derived from 3~(1-adamantoyl} indole, 3-(1-adamantoyl) indazole, or 3-(2-adamantoyl) indole by substitution at a nitrogen atom of the indole or indazole ring with alkyl, haloalkyl, alkenyl, cyancalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, 1+ (N-methy1~2- piperidinyl)methy1 or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole or indazole ring to any extent and whether or not substituted in the adamantly ring to any extent, including without limitation the following: aw (ay Gin ay ow (wi) aN-1248, or 1-adamantyl~[1~[{1-methylpiperidin-2- yl)methy1] indol~3-yl}methanone; AB-001, or 1-adamantyl-(1-pentylindol-3-yl)methanone; JWH=018 adamantyl carboxamide, or i-pentyl-N- tricyclo[3.3.1.13,7]dec-1-yl~1Ht~indole-3-carboxamide, some other names: 2NB1; AKB~48, or N=(1-adamantyl) ~penty1-1H-indazolo~3- carboxamic 5P-AKB=48, or N-((3s,5s, 7s) -adamantan-1-y1}-1-(5~ flucropentyl) -1H-indazole=3-carboxamides 818-135, or N-(1-adamantyl)~1~(5~f1ucropentyl) indole-3~ carboxamide: (9) Tetramethylcyclopropylcarbonylindoles ox any compound structurally derived from 3-(2,2,3,3- tetramethyicyclopropylearbonyl) indole by substitution at the nitrogen atom of the indole ring with alkyl,naloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethy] cycloalkylethyl, (N-methylpiperidin-2-yl)methyl or 2~(4~ morpholinyljethyl, whether or not further substituted in the indole ring to any extent, including without limitation the followin: a (11) (114) Gy) w UR-144, or (1-pentylindol-3-yl)~(2,2,3,3- tetramethylcyclopropyl)methanone; XUR-11, ox [1-(5-L2uoropentyl) ~1N-indol~3-yl)~(2,2,3,3> tetranethylcyclopropyl)methanone; A-796,260, or [1-(2-morpholin~4~yl~ethy1] ~1#~indol-3- yl] (2, 2,3, 3-tetramethylcyclopropyl}methanone; S-Chioro-UR-144, or ([=(5=chloropenty1)=1i-indol-3~ yh] (2, 2,3, 3-tetramethyleyclopropyl}methanone; 5-Bromo-UR-14, or (1~(5-bronopenty1) -1H-indol-3~ yl) (2,2,3,3-tetramethyleyclopropyl)methanone; andcy) Page 21 (vi) R-834,735, oF 1>(tetrahydropyran-4-ylmethy1) -1H-indol~3- yl}=(2,2, 3, 3-tetramethylcyclopropyl) methanones unclassified synthetic Cannabinoids, including without Limitation the following: aw aay ain av Ww way (wii (iii) (ax) cea) (xi) (xii) (iit) (xiv) ox) (xvi) (evil) (evil) (xix be) xxi exit) (eek) (xiv) cP §0556-1 hydrochloride, or { (6S, 6a, 9R, 10a) -9- hydroxy-6-methyl~3-| (28) -5phenylpentan-2-yl]oxy- 5,6,6a, 1,8, 9, 10, 10a-octahydrophenanthridin=1-y1] acetate: HU~210, o& (6aR, 10aR)-9- (hydroxymethyl) ~6, 6-dimethyl~ 3+(2-methyloctan-2-yi} ~6a, 7,10, 10a tetrahydrobenzo[c] chromen"1-01} 0-211, or Dexanabinol, (6aS, 10aS) ~9- (hydroxymethyl) ~ 6, 6-dimethy1-3- (2-methyLoctan=2-y1) 6a, 7,10, 10a~ tetrahydrobenzo[c]chromen-1-01; Dimethylheptylpyran or DMHP; WINS5, 212-2, or 2,3-Dihydro-5-methy1-3-( morpnolinylmethy) pyrrole(1,2,3-de)-1, -benzoxazin-6- yl-1-naphthalenylethanone: URBS97, oF [3-(3-carbamoylphenyl} phenyl} N- cyclohexylearbamate; URB754, oF 6-methyl~2-| (¢-methylphenyl) amino] I~ benzoxazin=4-one; (B-13, or 1-naphthaleny) [4~(pentyloxy) -1 naphthalenyl]-methanone; URB602, or cyclohexyl N-(3-phenylphenyl} carbamate; PB-22, or quinolin-B-yl 1=(5=pentyl)~1-indole-3- carboxylates 5F-PB-22, or quinolin-8-yl 1-(5-fluoropentyl) =1K~ indole-3~cazboxylate: BB-22, oF quinolin-@-yl 1-(eyelehexylmethyl)~18- indo le-3-carboxylates NNEI (MN-24), oy N-I-naphthalenyl-1-pentyl-ill-indole~ 3-carboxamide; SF-NNET, or 1-($-fluoropentyl) -N- (naphthalene-1-yL}~ 1B-indole-3-carboxamide; 5-Fluoro-AMB, or n=[ (1(5-fluoropentyl) ~1H-indazol-3— yl}carbonyl}-L-valine methyl ester; MMB=CUMICA, or methyl~(1-cyclohexylmethyl) ~1H~indole-3- carbonyl) -i-val inate; S-Pluoro-ADB, or methyl 2~(1~(5-f£1uoropenty1)~1H~ indazole~3-carboxamido)~3, 3-dimethylbutanoates S-Fluoro-MOMB-PICK, or methyl 2=(1~(5=fluoropentyl) ~ 1l-indole-3-carboxamido) ~3, 3-dimethylbutancate MOMB-CHMICA, or methyl 2-(1-(cyclohexylmethyl) =1#= indole-3-carboxamido) -3, 3-dimethylbutanoate FUB-AMB, or methyl 2~(17(4-f1uorobenzyl)-1N-indazole~ 3+carboxamido) -3-methylbutanoate; MOMB-FUBINACA, or methyl 2-(1-(4-£luorobenzyl) ~1N- indazole-3-carboxamido) 3, 3-dimethy1butanoates AB-PINACA, or N~(1~amino-3-methy1~1-oxobutan~2-y1) ~ L-pentyl-1#-indazole~3-caroboxamide; AB=CHMINACA, or N=(1-amino-3-methyl-1-oxobutan 2nyl) ~1- (cyclohexylmethyl) ~1#-indazole-3-carboxamide; MAB-CHMINACA, or N=(1-amino~3, 3-dimethyl~1~oxobutan- 2-yl)~1-(cyclohexylmethy)} ~1#-indazole-3-carboxamide,Page 22 (xxv) AB-FUBINACA, or N-(1-amino-3-methy1-1~oxobutan-2-yl) ~ 1+ (4-fluorobenzyl) ~1~indazole-3-carboxamide: (xvi) ADB-PINACK, ox N-(1amino~3, 3-dimethyl-1-oxobutan-2- yl) ~I-pentyl~1H~indazole-3-Carboxamide: (xxvii) SP-CUMYL-PINACA, of 1-(5~Cluvcopentyl) -N-(2- phenypropan-2-yl) ~1i-indazole~3-carboxamide. [6) A synthetic substance, derivative, or its isomers with: (A) Similar chemical ‘structure to any substance described in subdivisions (a) (1)~(5) of this section; or (B) Similar pharmacological effects to any substance described in Subdivisions (a) (1)-(5) of this section. (b) However, director shall not delete a controlled substance listed in this section from Schedule VI. (c) (1) Tf notice has been given to the director that the United States Food and Drug Administration has designated, rescheduled, or descheduled a marijuana~ derived substance under federal law and approved for marketing the marijuana- derived substance as 2 prescription medication, the director shall consider the designation, rescheduling, or descheduling of the marijuana-derived substance under this chapter. s-scheduled before Apeil, 1979. ‘*-Schedule VI is revised to conform to Act 329 of 2013,